Follow Slashdot stories on Twitter

 



Forgot your password?
typodupeerror
×
Medicine The Military United States

US Army Creates Single Vaccine Against All COVID, SARS Variants (defenseone.com) 248

Slashdot readers fahrbot-bot and Tangential share a report from Defense One: Within weeks, scientists at the Walter Reed Army Institute of Research expect to announce that they have developed a vaccine that is effective against COVID-19 and all its variants, even Omicron, as well as previous SARS-origin viruses that have killed millions of people worldwide. Walter Reed's Spike Ferritin Nanoparticle COVID-19 vaccine, or SpFN, completed animal trials earlier this year with positive results. Phase 1 of human trials, which tested the vaccine against Omicron and the other variants, wrapped up this month, again with positive results that are undergoing final review, Dr. Kayvon Modjarrad, director of Walter Reed's infectious diseases branch, said in an exclusive interview with Defense One. The new vaccine will still need to undergo phase 2 and phase 3 trials.

Unlike existing vaccines, Walter Reed's SpFN uses a soccer ball-shaped protein with 24 faces for its vaccine, which allows scientists to attach the spikes of multiple coronavirus strains on different faces of the protein. The vaccine's human trials took longer than expected, he said, because the lab needed to test the vaccine on subjects who had neither been vaccinated nor previously infected with COVID. The next step is seeing how the new pan-coronavirus vaccine interacts with people who were previously vaccinated or previously sick. The next step is seeing how the new pan-coronavirus vaccine interacts with people who were previously vaccinated or previously sick. Walter Reed is working with a yet-to-be-named industry partner for that wider rollout.

This discussion has been archived. No new comments can be posted.

US Army Creates Single Vaccine Against All COVID, SARS Variants

Comments Filter:
  • by CaptQuark ( 2706165 ) on Thursday December 23, 2021 @02:12AM (#62108515)

    Hopefully this was fully created by the Army and it will be free of the patent and big pharma entanglements of other vaccines. If it can be created easily and cheaply, other nations can produce the millions of doses they need.

    • Yes, that'd be great news, like Salk gave away his polio vaccine back in the day. Let's hope the common good of humanity prevails.
    • Hopefully they wonâ(TM)t a mistake as monumental as not patenting it. Because if they donâ(TM)t, somebody else will and will easily and succesfully sue the original inventors.

  • by Aighearach ( 97333 ) on Thursday December 23, 2021 @02:28AM (#62108529)

    The next step is seeing how the new pan-coronavirus vaccine interacts with people who were previously vaccinated or previously sick. The next step is seeing how the new pan-coronavirus vaccine interacts with people who were previously vaccinated or previously sick.

    In my opinion, they should plan to complete that step on the first attempt!

    Even if there is a chance of failure, you don't usually want failure to be the plan.

    • Isn't it standard procedure to get a second opinion?
    • I'm not disagreeing with you, but what supports your opinion?

    • >"In my opinion, they should plan to complete that step on the first attempt!"

      My fear with this type of multi-target vaccine is that it could cause an auto-immune storm of some sort or maybe just a wear response across the board. It might overwhelm the immune system with what looks to be many, many invaders at the same time. Maybe this doesn't work that way, I don't know.

      It is why I am not a fan of getting lots of different vaccinations AT THE SAME TIME (or too close together). I intentionally space o

  • by bloodhawk ( 813939 ) on Thursday December 23, 2021 @02:33AM (#62108537)
    Geez if the conspiracy nutters and anti vaxxers go off at the current crop of vaccines, just imagine the fallout from a US military developed one.
    • by AmiMoJo ( 196126 )

      The problem is that there have been issues attributed to US military vaccines in the past, like Gulf War Syndrome. I don't know enough about it to say if the claims were medically justified.

      • by fazig ( 2909523 )
        Weren't soldiers of "both sides" affected by Gulf War Syndrome?
        I'm not sure how a vaccine that only one side received would have caused that.

        If it was biological then, perhaps via a biological weapon that no-one knows of? Or a pathogen in the region at that time that no-one knows of?
        In any case, it ought to be something that affected a number of soldiers across the belligerents, be it biological, chemical, or something else, or protective measures that were taken (which could include vaccines) against t
        • People in that war zone were exposed to so much toxic stuff that it'd be surprising if many of them didn't suffer adverse health effects. There's still depleted uranium blowing around in the dust there causing all kinds of cancers.
          • by fazig ( 2909523 )
            Yeah, depleted uranium ammunition is some nasty shit.
            For the better part of this year I've studied ballistic science, including terminal ballistics. I see the superficial value of using DU for exterior and terminal ballistics. But if you consider the impact on health of those naturally incendiary projectiles (DU easily ignites on such high kinetic energy impacts) ... I don't even have words for the gross disregard of human life there. If the military was aware of the effects, which it ought to have, they w
            • I don't even have words for the gross disregard of human life there. If the military was aware of the effects, which it ought to have, they were deliberately, strategically fucking up that region for decades to come.
              A simple A10 pilot probably was not aware. Bu I know ti since roughly 1985, and at that time I was in highschool.
              So I would bluntly exaggerate and claim: "the military was/is aware".
              German tanks/airborn guns use Wolfram ammunition, it is not radioactive, but honestly: I have no clue if it is sig

              • by fazig ( 2909523 )
                I don't blame the soldiers. I blame the ones that made the decisions and should have known the facts.
                The terminal ballistics science concerning how high kinetic penetrators interact with armor dates back to the 60's.
                That uranium dust comes with bad health implication also isn't new.

                As far as I'm concerned depleted uranium for ammunition was chosen for basically 3 reasons.
                It's high density, which makes for a good material to increase the mass of a projectile while not having to increase the dimensions of
        • The "Gulf War Syndrom" is most likely heavy metal poisoning from uranium ammunition.

    • I'm someone you'd call either a conspiracy nutter or anti-vaxxer, but I see this vaccine as promising. The side effects from the mRNA vaccines seem to be caused by the spike protein itself (yes, they modified it to supposedly not cause harm, but that didn't work). My understanding of this new technology is admittedly lacking, but from the description in the summary above I'm hopeful that this larger inactive speck with protein spike attributes won't cause the severe reactions seen with the disease and the m
    • Re: (Score:2, Flamebait)

      by argStyopa ( 232550 )

      Yeah, it's normally the Left that's rabidly anti-government, anti-corporate, anti-big-pharma but even those normal historical issue cleave-lines have been subsumed by politics. Since Biden is president, the Left cheerfully (some might say blindly) supports huge pharma conglomerates and dosing hundreds of millions of people with vaccines that sidestepped the normal evaluation and approval process.

      Who'da thunk that it would take a little thing like a crisis to make the Left toss many of their fundamental bel

  • by battingly ( 5065477 ) on Thursday December 23, 2021 @02:49AM (#62108561)
    You need unvaccinated people for testing efficacy, but the remaining unvaccinated people out there probably aren't interested in volunteering for any vaccine studies.
    • by wickerprints ( 1094741 ) on Thursday December 23, 2021 @03:19AM (#62108603)

      Your observation brings up an interesting point that people working in drug development (specifically, clinical trial design) deal with quite often, which is, how do we determine efficacy in the indicated population if there already exists a standard of care treatment? In this case, as you noted, a large portion of the US population has already received vaccines, and the ones who have not are unlikely to volunteer for a clinical trial to determine the efficacy and safety profile of a new one.

      But in fact, this does not pose a significant problem: precisely because most people have been vaccinated, it is no longer of primary relevance to measure the efficacy in a vaccine-naive population. What you actually want to measure is how well this new vaccine performs compared to people who may have been previously vaccinated, but do not get this new vaccine--in other words, how much additional protection does this vaccine confer? The answer to that question is what the FDA will be looking at because if over half the US population has already gotten some kind of COVID vaccine, the way this new vaccine behaves (both in terms of efficacy and safety) in this population is just as important as how it might behave in a vaccine-naive population.

      A similar principle applies in general to many drugs with existing treatments. For example, the initial management of Type 2 diabetes often involves metformin, a widely used drug with an excellent safety profile. When new antidiabetic medications are researched, the trial sponsor isn't going to exclude patients who are metformin-naive for the sake of determining efficacy in a population with no previous antidiabetic therapy, because in real-world practice, patients already commonly have it prescribed to them.

      FIH (first in human) trials are a bit of a different story, because the goal is to establish that the drug is safe for the purposes of enrolling patients who have the condition the drug is supposed to treat. So these trials generally involve dose-escalation designs on a very small number of healthy subjects. For a vaccine, this would require enrollment of both vaccine-naive and vaccinated volunteers, because such a trial needs to establish that it is safe to enroll both of these groups in a larger Phase II trial.

      • by ffkom ( 3519199 )

        What you actually want to measure is how well this new vaccine performs compared to people who may have been previously vaccinated, but do not get this new vaccine--in other words, how much additional protection does this vaccine confer?

        Yes, but measuring this with statistical significant results is much more expensive than the initial clinical trials for "vaccinated vs. non vaccinated": It took a group of ~30k people and ~3 months to collect sufficient evidence for the protection against symptomatic disease, where the groups turned out to differ by a factor of 20 in terms of risk for symptomatic disease. Now if you need to collect similar solid evidence for the advantage of a new vaccine that, for example, provides 90% protection versus a

        • What you say is true, but it's not what the original issue was about, which was recruitment of unvaccinated people for large scale confirmatory trials. Your point, that the sample size needs to be substantially larger to measure a smaller effect size due to a population that already has some degree of immunity, may or may not be an actual problem. The reason why is because during the time the major vaccine trials were being conducted, the US was under lockdown, distancing was enforced, and there were no v

      • Not true. They have to test ALL probable recipient profiles to ensure safety for ALL probable profiles. 'Average' & 'generally safe' don't work when you're vaccinating 100s millions of people.
        • I did not say they did not need to enroll ANY unvaccinated people. Safety is highly unlikely to be worse in the unvaccinated population than in the previously vaccinated. And if it were, then anyone who is unvaccinated can get the old vaccines first, then get the new one--not that any of them would.

  • It's like the Army's fix-all for everything!

    • LOL- that was exactly what I was thinking.
      I didn't serve, but my cousin and girlfriend did, so I spent a lot of time on base.
      Broken bone? Motrin.
      Fever? Motrin.
      AIDS? Motrin.
  • Why are emergency use authorizations still a thing?

    • I agree. When would it ever be prudent to cut through bureaucracy to get something done, because it's time-sensitive?

      Imagine how much money we can save by not staffing Fire Stations 24 hours a day, or 911 call centers?
    • by bws111 ( 1216812 )

      You do know the 'zero liability' thing has nothing to do with EUAs, right?

  • In the middle of that soccerball is a nanobot hidden... Hasn't anyone seen the new Bond movie.
  • Could someone tell me about cures?
  • "Phase 1 of human trials, which tested the vaccine against Omicron and the other variants, wrapped up this month,"

    Yes, 100,000 soldiers were volunteered for this by their CO. :-)

  • What's the advantage of a giant framework with various spikes on it, versus just making a mixture of all the spikes?
  • Not quite (Score:4, Insightful)

    by jbmartin6 ( 1232050 ) on Thursday December 23, 2021 @08:18AM (#62108987)
    The description is missing an important word: KNOWN. As in "US Army Creates Single Vaccine Against All KNOWN COVID, SARS Variants". They can't attach a spike protein from a variant not yet in existence. This vaccine may or may not have any affect on the next variant, same as other vaccines we already have.
  • The summary reads like they've built a new, semi-universal delivery protein where they can mix-and-match strains for variable testing . . . that sounds positive and intelligent enough to be the summary

    So why does the title make it sound like it carries the correct mix-and-match of strains? Don't get me wrong, MMR is a godsend if you ask anyone who had to go through early age vaccines . . . another one would be great.

    Come on /. you don't have to bait us. If you're going to do that, just settle with a
  • by JoeRobe ( 207552 ) on Thursday December 23, 2021 @09:04AM (#62109095) Homepage

    This sounds like the equivalent of molecular Swiss Army knife. I'd be interested to see how quickly they can adapt it when a new strain comes out.

    On a related note does anyone know if every new modification to the mRNA vaccine, or I suppose this Army vaccine, needs to go through the same level of trials as the first batch?

  • This vaccine might be effective against a number of past variants. But none of these past variants are currently active. The evolution of the virus has moved on. The nature of virus evolution is that variants will keep popping up, and the ones that can survive will thrive. Surviving will include being able to thwart whatever new vaccine comes along, because any variant that is effectively controlled by a vaccine, by definition won't survive.

    A new vaccine is a good thing, but we should be cautious in our opt

    • by tsqr ( 808554 )

      But none of these past variants are currently active.

      I beg your pardon, but Alpha and Delta are currently quite active, and merrily killing around 2,000 people per day in the US.

  • Like, they've made balls out of lots of shapes, but the classic one has 60 faces, not 24. And there hasn't really been anything based around 24 faces. I mean, I guess a deltoidal icositetrahedron might look ball-ish if you squint at it?

"An idealist is one who, on noticing that a rose smells better than a cabbage, concludes that it will also make better soup." - H.L. Mencken

Working...